221 related articles for article (PubMed ID: 19023373)
1. [Drug resistance in HIV infection].
Asjö B; Langeland N
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2593-6. PubMed ID: 19023373
[TBL] [Abstract][Full Text] [Related]
2. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
Narciso P; Lazzarin A
Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
[TBL] [Abstract][Full Text] [Related]
3. [Viral drug resistance].
Dudman SG; Stene-Johansen K; Vik IS
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2597-600. PubMed ID: 19023374
[TBL] [Abstract][Full Text] [Related]
4. Genotypic resistance tests for the management of the patient failing highly active antiretroviral therapy: the resistance pattern in different biological compartments.
Liuzzi G
Scand J Infect Dis Suppl; 2003; 106():90-3. PubMed ID: 15000595
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
Hirsch MS; Günthard HF; Schapiro JM; Brun-Vézinet F; Clotet B; Hammer SM; Johnson VA; Kuritzkes DR; Mellors JW; Pillay D; Yeni PG; Jacobsen DM; Richman DD
Clin Infect Dis; 2008 Jul; 47(2):266-85. PubMed ID: 18549313
[TBL] [Abstract][Full Text] [Related]
6. [HIV-1 resistance against antiretroviral agents].
Asjø B; Ulvestad E
Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3421-4. PubMed ID: 11826790
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral drug resistance and resistance testing.
Gallant JE
Top HIV Med; 2005 Dec-2006 Jan; 13(5):138-42. PubMed ID: 16377851
[TBL] [Abstract][Full Text] [Related]
8. HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
[TBL] [Abstract][Full Text] [Related]
9. Resistance and replication capacity assays: clinical utility and interpretation.
Haubrich RH
Top HIV Med; 2004; 12(2):52-6. PubMed ID: 15184711
[TBL] [Abstract][Full Text] [Related]
10. New developments in HIV drug resistance.
Cane PA
J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018
[TBL] [Abstract][Full Text] [Related]
11. Understanding transmitted HIV resistance through the experience in the USA.
Taiwo B
Int J Infect Dis; 2009 Sep; 13(5):552-9. PubMed ID: 19136289
[TBL] [Abstract][Full Text] [Related]
12. Drug-resistant human immunodefiency virus.
Kozal MJ
Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():69-73. PubMed ID: 19220361
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
Cardoso LP; Queiroz BB; Stefani MM
J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
[TBL] [Abstract][Full Text] [Related]
14. Resistance to novel drug classes.
Marcelin AG; Ceccherini-Silberstein F; Perno CF; Calvez V
Curr Opin HIV AIDS; 2009 Nov; 4(6):531-7. PubMed ID: 20048722
[TBL] [Abstract][Full Text] [Related]
15. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.
Simen BB; Simons JF; Hullsiek KH; Novak RM; Macarthur RD; Baxter JD; Huang C; Lubeski C; Turenchalk GS; Braverman MS; Desany B; Rothberg JM; Egholm M; Kozal MJ;
J Infect Dis; 2009 Mar; 199(5):693-701. PubMed ID: 19210162
[TBL] [Abstract][Full Text] [Related]
16. Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.
Buzón MJ; Marfil S; Puertas MC; Garcia E; Clotet B; Ruiz L; Blanco J; Martinez-Picado J; Cabrera C
Antivir Ther; 2008; 13(7):881-93. PubMed ID: 19043922
[TBL] [Abstract][Full Text] [Related]
17. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
18. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
19. Emergence of HIV-1 drug resistance during antiretroviral treatment.
Rong L; Feng Z; Perelson AS
Bull Math Biol; 2007 Aug; 69(6):2027-60. PubMed ID: 17450401
[TBL] [Abstract][Full Text] [Related]
20. Incorporating drug-resistance measurements into the clinical management of HIV-1 infection.
Zolopa AR
J Infect Dis; 2006 Sep; 194 Suppl 1():S59-64. PubMed ID: 16921474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
